Trillium Therapeutics Inc (TRIL.TO)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [TSX]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [TSX]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 09-2016 | 06-2016 | 03-2016 | 12-2015 | 09-2015 | |
| Cash Flows From Operating Activities | |||||
| Depreciation Amortization | 859 | 890 | 629 | 76 | 89 |
| Income taxes - deferred | 45 | -9 | -2,842 | N/A | N/A |
| Accounts receivable | 431 | 394 | -396 | -103 | 84 |
| Other Working Capital | 1,011 | 581 | -276 | -423 | 472 |
| Other Operating Activity | -6,371 | -5,630 | -1,662 | -2,532 | -3,274 |
| Operating Cash Flow | $-4,025 | $-3,774 | $-4,548 | $-2,982 | $-2,629 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -60 | -641 | -1,383 | -152 | -309 |
| Net Acquisitions | 118 | -24 | -7,376 | N/A | N/A |
| Investing Cash Flow | $58 | $-666 | $-8,760 | $-152 | $-309 |
| Cash Flows From Financing Activities | |||||
| Debt Repayment | -21 | -20 | -24 | -22 | 26 |
| Common Stock Issued | 27 | 0 | 0 | -1,397 | -4,374 |
| Other Financing Activity | -45 | 72 | -6 | -6 | 135 |
| Financing Cash Flow | $-39 | $52 | $-30 | $-1,424 | $-4,214 |
| Exchange Rate Effect | 897 | -128 | -2,784 | 1,365 | 2,959 |
| Beginning Cash Position | 46,430 | 50,725 | 66,847 | 66,356 | 72,138 |
| End Cash Position | 42,252 | 46,430 | 50,725 | 62,529 | 66,356 |
| Net Cash Flow | $-4,005 | $-4,388 | $-13,337 | $-4,557 | $-7,152 |
| Free Cash Flow | |||||
| Operating Cash Flow | -4,025 | -3,774 | -4,548 | -2,982 | -2,629 |
| Capital Expenditure | -60 | -641 | -1,383 | -152 | -309 |
| Free Cash Flow | -4,084 | -4,415 | -5,931 | -3,134 | -2,938 |